Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 26,500 shares at $24.00 ($672K) on 2020-03-02, disclosed to the SEC on 2020-03-04.
Open-market sale of $672k KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.50 | 7,500 | $176K | 26.2% |
| 2 | $24.00 | 9,000 | $216K | 32.1% |
| 3 | $28.00 | 10,000 | $280K | 41.7% |
| Total | $25.37 avg | 26,500 | $672K | 100% |
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |